Claycomb, Julie M
$100,000.00 CAD
- Department
- Canadian Institutes of Health Research
- Program
- Research in Priority Areas
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- March 1, 2021 – February 28, 2022
- Reference
- cihr-irsc:236-2020-2021-Q4-00143
Published purpose
The overall goal of this pan-Canadian initiative is to position Canada for the rapid translation of epigenetic discoveries into diagnostic procedures and the eventual development of new therapeutics that can improve human health. By supporting and applying epigenetics research on a national scale, CEEHRC is harnessing its great potential for major breakthroughs in understanding the origins of health and also the etiology, treatment and prevention of many of the chronic diseases currently affecting the Canadian population. Specific CEEHRC objectives include: •Establishment of a national epigenetics platform that will serve as an essential resource for the generation of human reference epigenomes and that will coordinate national efforts in epigenomic research. •Translation of epigenetic research discoveries into clinical and medical practice by supporting large-scale epigenetics research. This includes the development of novel molecular tools for diagnostic and therapeutic applications to a wide range of complex disorders. •Positioning Canadian researchers, clinicians and policy-makers at the forefront of epigenetics science and its translation into health-care deliverables by playing a leadership role in IHEC and other international epigenetics initiatives.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.